Clinical Trials Browser

Recruiting × Interventional × Buserelin × Clear all

NCT05050084 2026-01-14

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Phase 3 Recruiting

Prostate Adenocarcinoma

NCT01492972 2025-09-04

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Phase 3 Recruiting

Prostatic Neoplasms